Reported Jul 1, 2026 · Ongoing · Updated Sep 16, 2026
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by:…
Ajanta Pharma USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Ajanta Pharma USA Inc · 400 Crossing Blvd Ste 102 · Bridgewater, NJ · 08807-2863
Is this the product you have?
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules
- Manufactured byAjanta Pharma Limited, India
- Marketed by
Ajanta Pharma USA Inc. BridgewaterNJ 08807NDC 27241-120-04
- Lot codes and dates
Lot # PA02216Exp. 12/2029
- Amount recalled
- 3648 bottles
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Ajanta Pharma USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.